Last year in October, the province of BC defunded the Therapeutics Initiative program, an independent institution to monitor the effects of prescription pharmaceutical drugs. TI is also attached to the University of British Columbia’s Department of Family Practice, and had been working in this capacity since 1994. Defunding from the province did not kill the program. Instead, UBC picked up the shortfall, but TI garnered itself international attention as they campaigned for recognition, nationally and internationally, earning a mention in the prestigious British Medical Journal, as well as an open letter from doctors and research scientists from around the world,.. READ MORE »
November 3, 2013
This week, we’re taking a look at some of the promising discoveries that have appeared over the last few months. They all share something in common: they all have roots in our ongoing efforts to understand the human genetic code and the biological processes surrounding it, part of a trend that’s opening up a whole range of new cures and treatments. Pharmaceutical discoveries and possible new treatments Messenger RNA (mRNA) normally serves an important role in copying DNA, as part of its transmission. Clinical research-oriented company, CureVac has partnered with pharmaceutical giant Janssen to build on existing, promising research. The.. READ MORE »
November 1, 2013
Since the Nobel Prize was awarded to Banting and Macleod in 1923 for their discovery of Insulin, Canada has held a place as one of the top countries for pharmaceutical research in the world. Canadian scientists are still being credited with breakthrough discoveries every year, and there is an explicit need for young talent to enter the industry. It is recognized that historically, young researchers are statistically more likely to conduct breakthrough research. Universities and corporate labs know this, and many commit themselves to finding fresh talent. CIHR, the Canadian Institute of Health Research specifically targets young scientists, offering numerous.. READ MORE »
October 24, 2013
As a student of pharmaceutical or life sciences (or anyone interested in how science is bettering our world), you will inevitably learn about the latest High Performance Liquid Chromatography (HPLC) techniques and how they fit into different industries. At this point, HPLC is an established technique dating back to the early twentieth century, but over the decades, the process has been refined and simplified. It has evolved from a multi-unit process to a standardized procedure with a single piece of laboratory equipment. HPLC works differently that traditional liquid chromatography because it uses a man-made high-pressure process instead of gravity to.. READ MORE »
October 19, 2013
We’ve talked extensively about pharmaceutical careers, but it’s important not to forget one of the other job paths at AAPS: Food safety training for food preparation and manufacturing. Every living person eats. As a result, food safety is a concern for everyone, at every level of the process, from first production to kitchen and all the way to the plate. It is unlikely that you would find a restaurant without food safety certification. In Canada, federal level regulation comes from the Canadian Food Inspection Agency, while individual provinces and municipalities prefer to add their own oversight. Food quality assurance and.. READ MORE »
October 12, 2013
We’ve talked a lot about what’s going on in the pharmaceutical industry, in Canada and in the world, but now we’re going to take it back to you, and look at some of the tips that will help you launch and grow your pharmaceutical career. Defining Your Goal– While it’s possible to launch a career with no clear direction plan; you’ll spend your time and effort more efficiently if you have an idea where to go. At AAPS, we pride ourselves on our industry experience, so our faculty can help you get started. But, asides from that, you need to.. READ MORE »
October 7, 2013
Astellas Pharma Canada has launched a BC campaign to build public awareness of their new incontinence treatments. Although both drugs are approved for sale in the country, currently neither has the approval for subsidy by BC’s Pharmacare. Rather than reaching out to the government via direct lobbying, Astellas is trying another solution and has launched a nationwide incontinence awareness campaign, “It’s Urgent” While every drug that’s approved in Canada can be sold in Canadian pharmacies, what the average consumer does not know is that not all pharmaceuticals are equally subsidized. Because Canadian health care is the responsibility of the province,.. READ MORE »
September 30, 2013
After the World Health Report launch for 2013, the WHO is calling on countries to improve their investment in local research to help develop better universal health coverage plans. Even in countries that prefer a more privatized system than Canada, governments have a strong role to play in making sure that health standards are maintained. There are many reasons for this. For example making sure that everyone eligible in a population receives vaccinations to childhood illnesses provides “herd immunity” meaning that if a disease is introduced into the population (for example, from a country that does not have the presence.. READ MORE »
September 29, 2013
China announces it is deepening its ongoing fraud investigation into the pharmaceutical industry. The probe seeks to make the Chinese market more competitive, removing corruption from the system to ensure that China’s standards for pharmaceuticals match the rest of the developed world. Although revelations of bribery and regulation evasion sound like a PR nightmare, in practice, it is part of the necessary growing pains to encourage more companies to invest in the country. While many major pharmaceutical companies have offices in the world’s most populous nation, including Eli Lily, Astra Zenca and Pfizer, and have had established footholds for decades,.. READ MORE »
September 28, 2013
The international pharmaceutical company, Pfizer, has announced a plan to break its entire structure into three segments, two focused on their Innovative line and one on their Value line. Pfizer employs nearly 3,000 Canadians in six locations across the country, and was ranked one of Canada’s top 100 employers for 2012 in a Globe and Mail survey. With products ranging from Celebrex to Chapstick, Pfizer has decided that the split will allow it the flexibility to function as three separate business entities. This is expected to come into effect in 2014, starting with countries that do not require prior union.. READ MORE »
September 7, 2013
1-855-502-2288